Status:
UNKNOWN
Autologous Bone Marrow Mononuclear Cells in Liver Cirrhosis
Lead Sponsor:
Universidade Federal do Rio de Janeiro
Collaborating Sponsors:
Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Conditions:
Liver Cirrhosis Due to Virus C Chronic Hepatitis
Eligibility:
All Genders
18-75 years
Phase:
PHASE1
Brief Summary
This is a phase I clinical study to evaluate feasibility, safety and kinetics of cellular therapy with autologous bone marrow-derived mononuclear cells (BMMC) in patients with liver cirrhosis due to v...
Eligibility Criteria
Inclusion
- Chronic virus C hepatitis
- Liver cirrhosis
- Moderate liver disfunction
Exclusion
- Malignant disease
- Pregnancy
- Significant comorbidity
- Portal vein thrombosis
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2010
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00832247
Start Date
January 1 2009
End Date
April 1 2010
Last Update
January 30 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitário Clementino Fraga Filho
Rio de Janeiro, Rio de Janeiro, Brazil, 21914-913